Turkish Journal of Anaesthesiology & Reanimation, vol.1, pp.1135-1136, 2020 (Peer-Reviewed Journal)
Hypercoagulopathy associated with COVID-19 is the leading cause of acute respiratory distress syndrome (ARDS),
multiple organ failure, and mortality (1). Several patients develop thrombotic complications due to this uncontrolled
immune thrombotic response which might be a major risk factor related to the development of ARDS and progression from ARDS to death (1). Extracorporeal membrane oxygenation (ECMO) has been used to manage patients
with COVID-19-associated severe respiratory or cardiac failure (2-4). We aim to summarise our experience with
deadly thrombotic complications during venovenous ECMO (vvECMO) treatment in 6 patients with COVID-19
associated ARDS between March and April, 2020.